Found: 30
Select item for more details and to access through your institution.
Commentary: short-term stability of subtypes in the irritable bowel syndromes - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 850, doi. 10.1111/j.1365-2036.2012.05008.x
- By:
- Publication type:
- Article
Predictors of severe outcomes associated with C lostridium difficile infection in patients with inflammatory bowel disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 789, doi. 10.1111/j.1365-2036.2012.05022.x
- By:
- Publication type:
- Article
Commentary: short-term stability of subtypes in the irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 849, doi. 10.1111/j.1365-2036.2012.05004.x
- By:
- Publication type:
- Article
Randomised clinical trial: efficacy of a new synbiotic formulation containing Lactobacillus paracasei B21060 plus arabinogalactan and xilooligosaccharides in children with acute diarrhoea.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 782, doi. 10.1111/j.1365-2036.2012.05015.x
- By:
- Publication type:
- Article
Letter: identification of probiotics by specific strain name - author's reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 860, doi. 10.1111/j.1365-2036.2012.05026.x
- By:
- Publication type:
- Article
Systematic review: cardiovascular safety profile of 5- HT<sub>4</sub> agonists developed for gastrointestinal disorders.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 745, doi. 10.1111/j.1365-2036.2012.05011.x
- By:
- Publication type:
- Article
Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 846, doi. 10.1111/j.1365-2036.2012.05019.x
- By:
- Publication type:
- Article
Letter: identication of probiotics by specific strain name.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 859, doi. 10.1111/j.1365-2036.2012.05010.x
- By:
- Publication type:
- Article
Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 861, doi. 10.1111/j.1365-2036.2012.05021.x
- By:
- Publication type:
- Article
Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 856, doi. 10.1111/j.1365-2036.2011.04985.x
- By:
- Publication type:
- Article
A comparison of the acid-inhibitory effects of esomeprazole and rabeprazole in relation to pharmacokinetics and CYP2 C19 polymorphism.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 810, doi. 10.1111/j.1365-2036.2012.05014.x
- By:
- Publication type:
- Article
Endoscopic evaluation of the gastro-duodenal tolerance of short-term analgesic treatment with 25 mg diclofenac- K liquid capsules.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 819, doi. 10.1111/j.1365-2036.2012.05030.x
- By:
- Publication type:
- Article
Corrigenda.
- Published in:
- 2012
- Publication type:
- Erratum
Commentary: effect of pregabalin on acid-induced oesophageal hypersensitivity.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 844, doi. 10.1111/j.1365-2036.2012.05018.x
- By:
- Publication type:
- Article
Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 847, doi. 10.1111/j.1365-2036.2012.05032.x
- By:
- Publication type:
- Article
Commentary: HBs Ag levels as predictor of sustained response to peginterferon in HBe Ag-negative chronic hepatitis B - author's reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 843, doi. 10.1111/j.1365-2036.2012.05020.x
- By:
- Publication type:
- Article
Letter: the ethics of using inferior regimens in H. pylori randomised trials.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 852, doi. 10.1111/j.1365-2036.2011.04944.x
- By:
- Publication type:
- Article
Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 828, doi. 10.1111/j.1365-2036.2012.05007.x
- By:
- Publication type:
- Article
Corrigenda.
- Published in:
- 2012
- Publication type:
- Erratum
Letter: liver dysfunction and survival in hepatocellular carcinoma treated by transarterial chemoembolisation - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 862, doi. 10.1111/j.1365-2036.2012.05042.x
- By:
- Publication type:
- Article
Chronic obstructive pulmonary disease: an independent risk factor for peptic ulcer bleeding: a nationwide population-based study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 796, doi. 10.1111/j.1365-2036.2012.05028.x
- By:
- Publication type:
- Article
Letter: the ethics of using inferior regimens in H. pylori randomised trials - invited comment.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 854, doi. 10.1111/j.1365-2036.2011.04951.x
- By:
- Publication type:
- Article
Review article: coeliac disease, new approaches to therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 768, doi. 10.1111/j.1365-2036.2012.05013.x
- By:
- Publication type:
- Article
Letter: the ethics of using inferior regimens in H. pylori randomised trials - editors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 858, doi. 10.1111/j.1365-2036.2012.05024.x
- By:
- Publication type:
- Article
Commentary: coeliac disease, mortality and malignancy - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 840, doi. 10.1111/j.1365-2036.2012.05017.x
- By:
- Publication type:
- Article
Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 848, doi. 10.1111/j.1365-2036.2012.05023.x
- By:
- Publication type:
- Article
Commentary: coeliac disease, mortality and malignancy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 839, doi. 10.1111/j.1365-2036.2012.05005.x
- By:
- Publication type:
- Article
Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 803, doi. 10.1111/j.1365-2036.2012.05016.x
- By:
- Publication type:
- Article
Commentary: HBs Ag levels as predictor of sustained response to peg interferon in HBe Ag-negative chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 842, doi. 10.1111/j.1365-2036.2012.05009.x
- By:
- Publication type:
- Article
Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease - authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 7, p. 849, doi. 10.1111/j.1365-2036.2012.05045.x
- By:
- Publication type:
- Article